Kim Kardashian’s Morning Sickness Ad Has Gotten Her in Trouble with the FDA
Kim Kardashian is in big trouble with the FDA.
The Food and Drug Administration has sent a warning letter to the drugmaker Duchesnay threatening to remove their drug off the market because of her endorsement.
In July, she posted a photo on Instagram promoting a “partnership” with the drug Diclegis, which helps combat morning sickness, however she didn’t mention any risks associated with the medicine.
For that reason, the FDA says Kardashian’s social media posts violate federal drug-promotion rules, calling the ad “false and misleading” for leaving out key facts about which drugs to avoid while taking Diclegis.
Kardashian has since deleted the post off Instagram and Facebook, but it’s still up on Twitter. This is what it read:
OMG. Have you heard about this? As you guys know my #morningsickness has been pretty bad. I tried changing things about my lifestyle, like my diet, but nothing helped, so I talked to my doctor. He prescribed me #Diclegis, and I felt a lot better and most importantly, it’s been studied and there was no increased risk to the baby.
So what does all this mean for the pregnant momma? The letter demands the company correct the problem by getting her to repost her endorsements with the proper warnings. In other words, it’s another excuse to post a selfie.